Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Brunskill, Eric W ^a   Potter, S Steven ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Diabetic nephropathy; Fibrosis; Mesangial cells

Indexed keywords

DECORIN; GROWTH FACTOR; THROMBOSPONDIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AGTR1A GENE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APBB2 GENE; ARID5B GENE; ARTICLE; CELL DIVISION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EBF1 GENE; ENDOTHELIUM CELL; ETS1 GENE; EXTRACELLULAR MATRIX; FIBROSIS; FLUORESCENCE ACTIVATED CELL SORTING; GATA3 GENE; GDF10 GENE; GENE; GENE EXPRESSION; GLOMERULUS; HDAC9 GENE; HOPX GENE; IL2RG GENE; IMMUNOHISTOCHEMISTRY; ITGA4 GENE; ITGA8 GENE; KIDNEY CELL; KLF12 GENE; LPHN3 GENE; MECOM GENE; MESANGIUM CELL; MFGE8 GENE; MOUSE; NONHUMAN; NR2F1 GENE; P2RX1 GENE; PAWR GENE; PDGFRB GENE; PHAGOCYTOSIS; PLA2R1 GENE; PODOCYTE; PTGER4 GENE; PTN GENE; RYBP GENE; S1PR3 GENE; SMOOTH MUSCLE; SNAI2 GENE; TLR4 GENE; TRPC1 GENE; UPREGULATION; ZEB2 GENE;

ANIMALS; DIABETIC NEPHROPATHIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MESANGIAL CELLS; MICE; MICE, TRANSGENIC;

EID: 84864189521     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-70     Document Type: Article

References (54)

1. Diabetic kidney disease: act now or pay later. Atkins RC, Zimmet P, Nephrol Dial Transplant 2010 25 2 331 333 10.1093/ndt/gfp757 20093271
2. Cell and matrix components of the glomerular mesangium in type I diabetes. Steffes MW, Bilous RW, Sutherland DE, Mauer SM, Diabetes 1992 41 6 679 684 10.2337/diabetes.41.6.679 1587395
3. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H, Kidney Int 2003 64 5 1632 1642 10.1046/j.1523-1755.2003.00263.x 14531794 (Pubitemid 37323690)
4. Static pressure regulates connective tissue growth factor expression in human mesangial cells. Hishikawa K, Oemar BS, Nakaki T, J Biol Chem 2001 276 20 16797 16803 10.1074/jbc.M010722200 11278731
5. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Mishra R, Leahy P, Simonson MS, Am J Physiol Renal Physiol 2002 283 5 1151 F1159 12372792
6. Effects of kynurenine metabolites on mesangial cell proliferation and gene expression. Yoshimura H, Sakai T, Kuwahara Y, Ito M, Tsuritani K, Hirasawa Y, Nagamatsu T, Exp Mol Pathol 2009 87 1 70 75 10.1016/j.yexmp.2009.02.002 19268458
7. Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. Simonson MS, Ismail-Beigi F, J Biol Chem 2011 286 13 11003 11008 10.1074/jbc.M110.190793 21169360
8. Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis. Sadlier DM, Ouyang X, McMahon B, Mu W, Ohashi R, Rodgers K, Murray D, Nakagawa T, Godson C, Doran P, et al. Kidney Int 2005 68 6 2542 2561 10.1111/j.1523-1755.2005.00661.x 16316330 (Pubitemid 43251000)
9. Defining the molecular character of the developing and adult kidney podocyte. Brunskill EW, Georgas K, Rumballe B, Little MH, Potter SS, PLoS One 2011 6 9 24640 10.1371/journal.pone.0024640 21931791
10. Atlas of gene expression in the developing kidney at microanatomic resolution. Brunskill EW, Aronow BJ, Georgas K, Rumballe B, Valerius MT, Aronow J, Kaimal V, Jegga AG, Yu J, Grimmond S, et al. Dev Cell 2008 15 5 781 791 10.1016/j.devcel.2008.09.007 19000842
11. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Chen J, Bardes EE, Aronow BJ, Jegga AG, Nucleic Acids Res 2009 37 305 W311 19465376
12. ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ, Nucleic Acids Res 2010 38 Web Server issue 96 W102 20484371
13. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, Genome Res 2003 13 11 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
14. Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations. Hernandez AM, Villamar M, Rosello L, Moreno-Pelayo MA, Moreno F, Del Castillo I, Am J Med Genet A 2007 143 7 757 762 17309062 (Pubitemid 46606688)
15. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Wieser R, Gene 2007 396 2 346 357 10.1016/j.gene.2007.04.012 17507183 (Pubitemid 46935408)
16. Par-4 inducible apoptosis in prostate cancer cells. Gurumurthy S, Rangnekar VM, J Cell Biochem 2004 91 3 504 512 10.1002/jcb.20000 14755681
17. PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein. Xie J, Guo Q, J Biol Chem 2005 280 14 13824 13832 10.1074/jbc.M411933200 15671026 (Pubitemid 40517280)
18. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, et al. Mol Cell Biol 1996 16 12 6945 6956 8943350 (Pubitemid 26389754)
19. Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Guenette SY, Chen J, Jondro PD, Tanzi RE, Proc Natl Acad Sci U S A 1996 93 20 10832 10837 10.1073/pnas.93.20. 10832 8855266 (Pubitemid 26333075)
20. The apoptosis inhibitory domain of FE65-like protein 1 regulates both apoptotic and caspase-independent programmed cell death mediated by tumor necrosis factor. Lange A, Thon L, Mathieu S, Adam D, Biochem Biophys Res Commun 2005 335 2 575 583 10.1016/j.bbrc.2005.07.125 16083851 (Pubitemid 41140260)
21. Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta. Watanabe M, Layne MD, Hsieh CM, Maemura K, Gray S, Lee ME, Jain MK, Circ Res 2002 91 5 382 389 10.1161/01.RES.0000033593.05545.7B 12215486 (Pubitemid 35034205)
22. PDGF signaling specificity is mediated through multiple immediate early genes. Schmahl J, Raymond CS, Soriano P, Nat Genet 2007 39 1 52 60 10.1038/ng1922 17143286 (Pubitemid 46026501)
23. Hop is an unusual homeobox gene that modulates cardiac development. Chen F, Kook H, Milewski R, Gitler AD, Lu MM, Li J, Nazarian R, Schnepp R, Jen K, Biben C, et al. Cell 2002 110 6 713 723 10.1016/S0092-8674(02)00932-7 12297045 (Pubitemid 35283961)
24. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, et al. Diabetes 2010 59 7 1794 1802 10.2337/db09-1736 20393144
25. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, Karsan A, J Exp Med 2007 204 12 2935 2948 10.1084/jem.20071082 17984306 (Pubitemid 350179562)
26. Transcription factor Ets-1 in cytokine and chemokine gene regulation. Russell L, Garrett-Sinha LA, Cytokine 2010 51 3 217 226 10.1016/j.cyto.2010.03. 006 20378371
27. Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia. Orr B, Vanpoucke G, Grace OC, Smith L, Anderson RA, Riddick AC, Franco OE, Hayward SW, Thomson AA, Prostate 2011 71 3 305 317 10.1002/pros.21244 20812209
28. Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Perez-Pinera P, Alcantara S, Dimitrov T, Vega JA, Deuel TF, Proc Natl Acad Sci U S A 2006 103 47 17795 17800 10.1073/pnas.0607299103 17098867 (Pubitemid 44852239)
29. Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. Svensson SL, Pasupuleti M, Walse B, Malmsten M, Morgelin M, Sjogren C, Olin AI, Collin M, Schmidtchen A, Palmer R, et al. J Biol Chem 2010 285 21 16105 16115 10.1074/jbc.M109.081232 20308059
30. SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions. Raymond A, Ensslin MA, Shur BD, J Cell Biochem 2009 106 6 957 966 10.1002/jcb.22076 19204935
31. Pericyte-derived MFG-E8 regulates pathologic angiogenesis. Motegi S, Leitner WW, Lu M, Tada Y, Sardy M, Wu C, Chavakis T, Udey MC, Arterioscler Thromb Vasc Biol 2011 31 9 2024 2034 10.1161/ATVBAHA.111.232587 21737783
32. Potentiation of platelet-derived growth factor receptor-beta signaling mediated by integrin-associated MFG-E8. Motegi S, Garfield S, Feng X, Sardy M, Udey MC, Arterioscler Thromb Vasc Biol 2011 31 11 2653 2664 10.1161/ATVBAHA.111. 233619 21868707
33. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM, Am J Physiol 1998 274 1 Pt 2 43 F50 9458822
34. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Soriano P, Genes Dev 1994 8 16 1888 1896 10.1101/gad.8.16.1888 7958864
35. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G, Levkau B, Circ Res 2011 108 3 314 323 10.1161/CIRCRESAHA.110.235028 21164103
36. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, Hirano K, Usui S, Wang F, Du W, et al. Cardiovasc Res 2010 85 3 484 493 10.1093/cvr/cvp312 19755413
37. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG, J Am Soc Nephrol 2007 18 6 1732 1739 10.1681/ASN.2006060634 17460147 (Pubitemid 46870310)
38. Diabetic kidney disease in the db/db mouse. Sharma K, McCue P, Dunn SR, Am J Physiol Renal Physiol 2003 284 6 1138 F1144 12736165
39. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO, J Clin Invest 1998 101 5 982 992 10.1172/JCI1684 9486968 (Pubitemid 28125276)
40. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N, Cell 1998 93 7 1159 1170 10.1016/S0092-8674(00)81460-9 9657149 (Pubitemid 28307421)
41. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. Ziyadeh FN, J Am Soc Nephrol 2004 15 Suppl 1 55 S57 14684674
42. Thrombospondin secretion by cultured human glomerular mesangial cells. Raugi GJ, Lovett DH, Am J Pathol 1987 129 2 364 372 3314532 (Pubitemid 18007989)
43. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM, Diabetologia 2005 48 12 2650 2660 10.1007/s00125-005-0006- 5 16270194 (Pubitemid 41738234)
44. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Adler SG, Feld S, Striker L, Striker G, LaPage J, Esposito C, Aboulhosn J, Barba L, Cha DR, Nast CC, Kidney Int 2000 57 5 2084 2092 10.1046/j.1523-1755.2000.00058.x 10792628 (Pubitemid 30252301)
45. Decreased degradative enzymes in mesangial cells cultured in high glucose media. Leehey DJ, Song RH, Alavi N, Singh AK, Diabetes 1995 44 8 929 935 10.2337/diabetes.44.8.929 7621999
46. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Lam S, van der Geest RN, Verhagen NA, Daha MR, van Kooten C, Nephrol Dial Transplant 2004 19 7 1694 1701 10.1093/ndt/gfh235 15150349 (Pubitemid 38961376)
47. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Whiteside CI, Dlugosz JA, Am J Physiol Renal Physiol 2002 282 6 975 F980 11997313
48. Identification of human endomucin-1 and 2 as membrane-bound O-sialoglycoproteins with anti-adhesive activity. Kinoshita M, Nakamura T, Ihara M, Haraguchi T, Hiraoka Y, Tashiro K, Noda M, FEBS Lett 2001 499 1-2 121 126 11418125 (Pubitemid 32539334)
49. Role of annexins in endocytosis of antigens in immature human dendritic cells. Larsson M, Majeed M, Ernst JD, Magnusson KE, Stendahl O, Forsum U, Immunology 1997 92 4 501 511 10.1046/j.1365-2567.1997.00377.x 9497492 (Pubitemid 27525222)
50. Annexin A3 is a potential angiogenic mediator. Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S, Biochem Biophys Res Commun 2005 337 4 1283 1287 10.1016/j.bbrc.2005.10.004 16236264 (Pubitemid 41505261)
51. Effects of pioglitazone on the transdifferentiation and CTGF expression of renal tubular epithelial-myofibroblast in vitro. Pu L, Fan JM, Sichuan Da Xue Xue Bao Yi Xue Ban 2010 41 1 15 19 20369462
52. Decorin-transforming growth factor- interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. Ferdous Z, Wei VM, Iozzo R, Hook M, Grande-Allen KJ, J Biol Chem 2007 282 49 35887 35898 10.1074/jbc.M705180200 17942398 (Pubitemid 350277129)
53. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S, Exp Eye Res 2010 91 2 238 245 10.1016/j.exer.2010.05.013 20546727
54. Decorin deficiency enhances progressive nephropathy in diabetic mice. Williams KJ, Qiu G, Usui HK, Dunn SR, McCue P, Bottinger E, Iozzo RV, Sharma K, Am J Pathol 2007 171 5 1441 1450 10.2353/ajpath.2007.070079 17884968 (Pubitemid 350158306)